创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels: Features of the 3D Organoid Platform

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-02-23 14:58
  • Views:

(Summary description)In today's field of medical research, the 3D organoid platform from InnoModels is attracting a great deal of attention. This platform provides scientists with a revolutionary tool to more accurately mimic the structure and function of human organs, thereby advancing drug discovery, disease treatment, and basic science research

InnoModels: Features of the 3D Organoid Platform

(Summary description)In today's field of medical research, the 3D organoid platform from InnoModels is attracting a great deal of attention. This platform provides scientists with a revolutionary tool to more accurately mimic the structure and function of human organs, thereby advancing drug discovery, disease treatment, and basic science research

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-02-23 14:58
  • Views:
Information

In today's field of medical research, the 3D organoid platform from InnoModels is attracting a great deal of attention. This platform provides scientists with a revolutionary tool to more accurately mimic the structure and function of human organs, thereby advancing drug discovery, disease treatment, and basic science research. The features of the 3D organoid platform are described below:
1. Simulates the structure and function of real organs
The 3D organoid platform of InnoModels Biotechnology can accurately simulate the structure and function of human organs. Through precise cell culture technology and bioprinting technology, the platform can construct microstructures and histological features similar to those of real organs, and at the same time simulate the functions of organs, such as respiration, excretion, metabolism, etc., which provides researchers with an experimental environment close to the real situation.
2. Diversified organoid models
InnoModels' platform covers a wide range of different organoid models, including but not limited to the heart, liver, lungs, kidneys, and more. Each model is carefully designed to reflect the physiological and pathological characteristics of the corresponding organ, providing researchers with a wide range of options to meet the needs of different research fields.
3. Highly controllable experimental conditions
InnoModels' platform allows researchers to have a high degree of control over experimental conditions, including cell type, media components, and incubation time. This controllability allows researchers to design and execute various types of experiments to address specific scientific questions and obtain reliable experimental results.

 


4. Real-time monitoring and analysis
The platform is equipped with advanced real-time monitoring and analysis equipment that allows real-time monitoring and analysis of cellular activity, metabolic activity, and more. This real-time monitoring can provide important information about cellular reactions and interactions, providing researchers with deeper insights.
5. Application to drug screening and toxicity testing
The 3D organoid platform of InnoModels Biotechnology has been widely used in drug screening and toxicity testing. Through the platform, researchers can evaluate the effects of new drugs on different organs and predict the efficacy and toxicity of drugs, thus accelerating the process of drug development and reducing the number and cost of animal experiments.
Conclusion
By simulating the structure and function of real organs, the 3D organoid platform of InnoModels Biotechnology provides scientists with a brand new tool to promote the progress of drug development, disease treatment and basic science research. With the continuous innovation and development of the technology, it is believed that the platform of InnoModels Biotechnology will play an increasingly important role in the field of medical research.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司